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Toward a rapid and accurate point-of-care test
for active pulmonary tuberculosis: Multiplexed
proteomic assay (SOMAscanTM) of human
serum for microbial and host markers
M.A. De Groote, L. Green, D. Sterling, R. Ostroff, N.
Janjic, U. Ochsner
Somalogic, Boulder, USA
Background: A rapid, accurate, and inexpensive tuberculosis
(TB)diagnostic testwouldallowearlier treatmentandreduce trans-
mission.
Methods&Materials:Weused slowoff-ratemodiﬁedaptamers
(SOMAmers) in a highly multiplexed proteomic assay (SOMAscan)
to measure 1129 human proteins and 16 Mtb proteins in serum
samples provided by the Foundation for Innovative New Diagnos-
tics (FIND).
Results: Among the top host serum biomarkers distinguishing
TB from non-TB regardless of the HIV status were kallistatin, TSP4,
gelsolin, and CDON, which were lower in TB compared to non-
TB, and LBP, ITI heavy chain H4, NPS-PLA2, and IP-10, which were
higher in TB.
A 9-marker model performed well in a training set of 173
TB vs. 160 non-TB samples (sens 89% / spec 88%, AUC=0.94), which
was conﬁrmed in a blinded veriﬁcation set of 132 TB vs. 118
non-TB (sens 80% / spec 84%, AUC=0.88). Mtb pathogen-speciﬁc
SOMAmers showed non-speciﬁc background in serum and are
pending analytical optimization to improve performance. Addi-
tional work to improve sensitivity of the host markers is ongoing.
Conclusion: The discovery of robust, quantitative, non-culture
based diagnostic biomarkers of active pulmonary TB has great
potential to facilitate the rapid and accurate diagnosis of TB dis-
ease. Our goal is that a combined host and microbial point-of-care
diagnostic test could ultimately be tested and applied in peripheral
microscopy centers or in primary care clinics.
http://dx.doi.org/10.1016/j.ijid.2014.03.1172
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Identiﬁcation and evaluation of Schistosoma
mansoni proteins as diagnostic targets for
schistosomiasis
P. Ogongo
Institute of Primate Research, Nairobi, Kenya
Background: Demonstration of schistosome eggs in stool/urine
is the deﬁnitive clinical test for clinical examination of schisto-
somiasis but this test has low sensitivity. Antibody based assays
cannot distinguish between past and active infections thus unsuit-
able for follow up after drug administration while molecular
techniques are expensive and unavailable at the point of care cen-
ters. Bioinformatics and Proteomics can be used to characterize
schistosome proteins from different life cycle stages that include
worm gut, worm tegument, egg secretions or released products
of dead eggs that are released into the bloodstream and/or urine
forming good diagnostic targets.
Methods&Materials:Wehave identiﬁed ﬁve schistosome pro-
teins; Cathepsin B (Sm31), Asaparaginyl endopeptidase (Sm32),
schistosome alpha-2 macroglobulin, Sm LMWP and Sm200 tegu-
ment protein using these approaches. Peptide sequences from
these proteins synthesized as multiple antigenic peptides (MAPs)
or conjugated to carrier proteins were used to immunize rats
and rabbits. Serum from immunized rats were used to test the
suitability of these targets using Enzyme Assays, Blot Assays and
Immunocytochemistry with worm sections.
Results: Results show that antibodies to MAPs have good speci-
ﬁcity for the peptides and native schistosome antigens while
coupling to carrier proteins improves the immunogenicity of the
peptides.
Conclusion: This approach has shown that these peptides are
possible diagnostic targets that can be developed further to assess
their sensitivity aiming at developing an assay capable of detecting
the lowest number of worms in the host.
http://dx.doi.org/10.1016/j.ijid.2014.03.1173
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Rapid detection of ESBL-producing
Enterobacteriaceae from blood cultures: A
prospective study
P. Nordmann1, L. Poirel1, L. Dortet2
1 University of Fribourg, Fribourg, Switzerland
2 Hopital de Bicetre, Kremlin-Bicetre, France
Background: Enterobacterial strains producing clavulanic-
acid inhibited extended-spectrum beta-lactamases (ESBLs) are
increasingly reported worldwide. The rapid detection of ESBL-
producing Enterobacteriaceae responsible for bacteremia is of
utmost importance since their successful treatment depends on
prompt administrationof the appropriate antimicrobial agents. The
ESBL NDP test has been evaluated here prospectively to detect
ESBL-producing Enterobacteriaceae directly from blood cultures.
Methods & Materials: From November 2012 to May 2013, the
ESBL NDP test, a rapid chromogenic test based on detection of cefo-
taxime hydrolysis, was performed with 96 blood cultures positive
for Gram negatives. Results of the ESBL NDP test, obtained in less
than 30min, were compared to those obtained with the double
disk diffusion technique. All ESBLs were then characterized at the
molecular level. Identiﬁcation of the Gram-negative bacteria was
also performed directly on positive blood cultures using MALDI-
TOF technology, and conﬁrmed by a biochemical identiﬁcation.
Results: Eighteen blood cultures infected with ESBL-producing
Enterobacteriaceae (15 CTX-M producing E. coli and 3 CTX-M
producing K. pneumoniae) were correctly detected, whereas 78
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infected bynon-ESBL-producing isolates gave negative resultswith
the ESBL NDP test. Results of the ESBL NDP test were 100% corre-
latedwith those of the double disk-diffusionmethodwith themain
advantage that theywere obtained in less than30mindirectly from
the clinical sample versus an additive 24h time of incubation for
the double disk-diffusion method.
Conclusion: Using the ESBL NDP test, identiﬁcation of an ESBL
producer responsible for a bacteremia can be reduced from 24-
48hours to 30min with 100% sensibility, 100% speciﬁcity, 100%
negative predictive value and 100% positive predictive value. Since
the successful treatment of septicemia depends on prompt admin-
istration of the appropriate antimicrobial agents, use of the ESBL
NDP test directly from positive blood cultures may signiﬁcantly
improve the outcome of infected patients.
http://dx.doi.org/10.1016/j.ijid.2014.03.1174
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A case of chronic meningitis caused by
Cryptococcus neoformans, which was detected
only with the use of mycobacterial blood
culture bottle for cerebrospinal ﬂuid
H. Matsuo, K. Iwata
Kobe University, Kobe, Hyogo, Japan
Background: Cryptococcus is known to cause chronic meningi-
tis. Diagnosis is usually made with the use of cryptococcus antigen
test of cerebrospinal ﬂuid (CSF). Despite its high sensitivity, false
negative result can occur, particularly then the amount of the
organism in CSF was small. We herein report a case of cryptococcal
meningitis in a non-HIV patient, with negative india ink, negative
CSF cryptococcal antigen test, negative routine CSF fungal culture,
andpositiveonlywith theuseofmycobacterial bloodculturebottle.
Methods & Materials: The patient is 38-year-old man without
signiﬁcant pastmedical history,whopresentedwith gait instability
for 40 days. He also complained of intermittent headache since 20
days prior to the ﬁrst visit, which worsened gradually. He started
to feel weak on his left lower extremity, and had difﬁculty in stand-
ings up. On physical examination, he was alert but disoriented. His
neck was supple, but had gait instability. Head magnetic resonance
imaging study only showed widening of lateral ventricles. Cere-
brospinal ﬂuid examination revealed opening pressure was 24.5
cmH2O, cell count 143/L with 87% polymorphonuclear cells, pro-
tein 184mg/dL, glucose 7mg/dL, with negative Gram staining, acid
fastbacilli staining, india ink staining, andcryptococcal antigen test.
Results: Cryptococcus neoformans var grubii was detected only
from mycobacterial culture bottle 7 days later, despite negative
routine fungal culture. He was treated with amphotericin B lipid
complex and ﬂucytosine, together with spinal drainage, followed
by ﬂuconazolemaintenance therapy for 6months. His neurological
abnormalities improved without recurrence
Conclusion:Cryptococcal antigen test ofCSFhashigh sensitivity
for the diagnosis of meningitis, but false negative still can occur.
Previous studies suggest that theuseofmycobacterial bloodculture
bottle may increase the sensitivity of fungemia in general. There is
no literature reporting theuseofmycobacterial bloodculturebottle
for the diagnosis of cryptococcal meningitis. The use of it on CSF,
on top of conventional work up, may heighten the diagnostic yield
of this infection.
http://dx.doi.org/10.1016/j.ijid.2014.03.1175
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Utilization of malaria diagnostic tests and
receipt of anti-malarial drugs by febrile patients
attending outpatient departments of health
center IVs in Mukono district, Uganda
R. Naigino1, H. Babikako1, A. Katamba2, A.
Mukose2
1 Makerere University School of Public Health,
Kampala, Uganda
2 Makerere University, Kampala, Uganda
Background: Failure to demonstrate the presence of malaria
parasites prior to treatment with anti-malarial drugs remains a
challenge in Uganda, often resulting into over-prescription of anti-
malarial drugs to febrile patients suspected of malaria. The aim of
this studywas to describe the role of utilization ofmalaria diagnos-
tic tests and associated factors in the receipt of anti-malarial drugs
among febrile patients suspected of malaria.
Methods & Materials: In a cross-sectional study design, client-
exit interviews with febrile patients and key-informant interviews
withpurposively selectedhealthworkerswere conducted at health
center IVs in Mukono district. Data entry and analysis were done
using Epi-Data 3.2 and STATA 10 respectively. Data were described
using frequency distributions andproportions. Chi squarewas used
in two by two tables, odds ratios as the measure of association and
an alpha level of 0.05 was used in all signiﬁcance tests.
Results: Out of 408 respondents, 359 (88%) utilized malaria
diagnostic tests and 241(59%) received antimalarial drugs. Major-
ity were female 252 (61.8%) and a third of the sample was aged ﬁve
years and below. There were no statistically signiﬁcant differences
between utilizers and non-utilizers in most characteristics except
age, history of indoor residual spraying and satisfaction with ser-
vices. Utilizers were 75% less likely to receive anti-malarial drugs
than non-utilizers after controlling for age, sex and residence (OR:
0.25, 95%CI: 0.09, 0.66).
Power was the main limitation to microscopic diagnosis of
malaria and laboratory personnel had limited knowledge on
malaria treatment guidelines.
Conclusion: Utilizers were 75% less likely to receive anti-
malarial drugs as opposed to non-utilizers. This implies that
increasing utilization of malaria diagnostic tests can reduce the
problem of overprescription of anti-malarial drugs by 75% among
those tested formalaria, sinceantimalarial drugswill be receivedby
only those with a parasitologically-conﬁrmed diagnosis of malaria.
http://dx.doi.org/10.1016/j.ijid.2014.03.1176
